Physician profile
Monique Collins
NPI 1154885853
$2,611.03
in general payments reported to CMS, 2019-2025
20 companies · $37.95 in 2025
The $37.95 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2022: $421 · 2023: $549 · 2024: $1,317 · 2025: $37.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,903.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $555.69 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $395.28 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $279.64 | 2023-2024 | Airsupra, Breztri |
| Biohaven Pharmaceuticals, INC. | $240.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $158.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.85 | 2022-2024 | |
| Glaxosmithkline, LLC. | $119.98 | 2024-2025 | Nucala, Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $119.55 | 2023 | Rexulti |
| Pfizer INC. | $98.29 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $97.72 | 2023-2024 | Caplyta |
| Lilly USA, LLC | $93.77 | 2022-2024 | Mounjaro |
| Novo Nordisk INC | $61.92 | 2024 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $56.57 | 2023-2024 | Otezla, Repatha |
| Dexcom, INC. | $51.93 | 2022-2024 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $34.79 | 2023-2024 | Twirla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $23.40 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Idorsia Pharmaceuticals US INC | $22.17 | 2022 | |
| Ironwood Pharmaceuticals, INC | $19.58 | 2024 | |
| Exact Sciences Corporation | $15.62 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $14.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.